What is Medtronic's proceeds from issuance of shares?

Medtronic (MDT) reported proceeds from issuance of shares of $95.00M in Q2 2025.

How has Medtronic's proceeds from issuance of shares changed year-over-year?

Medtronic's proceeds from issuance of shares increased by 6.7% year-over-year, from $89.00M to $95.00M.

What is the long-term trend for Medtronic's proceeds from issuance of shares?

Over 4 years (2021 to 2025), Medtronic's proceeds from issuance of shares has grown at a 1.7% compound annual growth rate (CAGR), from $474.00M to $508.00M.

Other

Proceeds from issuance of shares

Medtronic Proceeds from issuance of shares decreased by 12.0% to $95.00M in Q2 2025 compared to the prior quarter. Year-over-year, this metric grew by 6.7%, from $89.00M to $95.00M. Over 4 years (FY 2021 to FY 2025), Proceeds from issuance of shares shows relatively stable performance with a 1.7% CAGR.

Analysis

StatementIncome Statement

SectionOther

First reportedQ1 2014

Last reportedQ1 2026Aug 26, 2025

Metric ID: other_proceeds_from_issuance_or_sale_of_equity

Historical Data

18 periods

	Q4 '21	Q1 '22	Q2 '22	Q3 '22	Q4 '22	Q1 '23	Q2 '23	Q3 '23	Q4 '23	Q1 '24	Q2 '24	Q3 '24	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26
Value	$160.00M	$111.00M	$42.00M	$191.00M	$85.00M	$43.00M	$106.00M	$60.00M	$99.00M	$77.00M	$155.00M	$0.00	$78.00M	$89.00M	$166.00M	$145.00M	$108.00M	$95.00M
QoQ Change	—	-30.6%	-62.2%	+354.8%	-55.5%	-49.4%	+146.5%	-43.4%	+65.0%	-22.2%	+101.3%	-100.0%	—	+14.1%	+86.5%	-12.7%	-25.5%	-12.0%
YoY Change	—	—	—	—	-46.9%	-61.3%	+152.4%	-68.6%	+16.5%	+79.1%	+46.2%	-100.0%	-21.2%	+15.6%	+7.1%	—	+38.5%	+6.7%

Range$0.00 – $191.00M

CAGR-11.5%

Avg YoY Growth+4.9%

Median YoY Growth+7.1%

Current Streak3 quarters decline

Frequently Asked Questions

What is Medtronic's proceeds from issuance of shares?: Medtronic (MDT) reported proceeds from issuance of shares of $95.00M in Q2 2025.
How has Medtronic's proceeds from issuance of shares changed year-over-year?: Medtronic's proceeds from issuance of shares increased by 6.7% year-over-year, from $89.00M to $95.00M.
What is the long-term trend for Medtronic's proceeds from issuance of shares?: Over 4 years (2021 to 2025), Medtronic's proceeds from issuance of shares has grown at a 1.7% compound annual growth rate (CAGR), from $474.00M to $508.00M.